Publications by authors named "I Ferrer Lopez"

Objective: NCTF135HA, a versatile polyrevitalizing solution, is a potent agent for enhancing skin quality, radiance, moisture, vitality, and diminishing fine wrinkles caused by aging factors. Data demonstrate a divergence in its application from skin quality enhancement to treatment of vitiligo lesions. To know more precisely about the protocol of use among providers, alone or in combination with other procedures, we performed an international survey.

View Article and Find Full Text PDF

The U4 small nuclear RNA (snRNA) forms a duplex with the U6 snRNA and, together with U5 and ∼30 proteins, is part of the U4/U6.U5 tri-snRNP complex, located at the core of the major spliceosome. Recently, recurrent variants in the U4 RNA, transcribed from the gene, and in at least two other genes were discovered to cause neurodevelopmental disorder.

View Article and Find Full Text PDF

Large language models (LLMs) with retrieval-augmented generation (RAG) have improved information extraction over previous methods, yet their reliance on embeddings often leads to inefficient retrieval. We introduce CLinical Entity Augmented Retrieval (CLEAR), a RAG pipeline that retrieves information using entities. We compared CLEAR to embedding RAG and full-note approaches for extracting 18 variables using six LLMs across 20,000 clinical notes.

View Article and Find Full Text PDF

Correctional facilities serve as a key location to identify and treat those with HIV given high rates of HIV seen in justice-involved individuals; however, substantial barriers exist to accessing HIV care in the community upon release. In response to restricted in-person activities due to COVID-19, the County of Santa Clara (SCC) Jail launched a telephonic visits program in January 2021 to link justice-involved individuals diagnosed with HIV to community HIV care following release. Telephonic visits were conducted by social workers from SCC Public Health Department; these visits entailed conducting an HIV needs assessment, providing education, and offering support services.

View Article and Find Full Text PDF

Paclitaxel is a widely used chemotherapeutic agent for the treatment of breast cancer (BC), including as a front-line treatment for triple-negative breast cancer (TNBC) patients. However, resistance to paclitaxel remains one of the major causes of death associated with treatment failure. Multiple studies have demonstrated that miRNAs play a role in paclitaxel resistance and are associated with both disease progression and metastasis.

View Article and Find Full Text PDF